Finding Your Place in Science
Welcome to ESWI Airborne: Shaping the Future of Respiratory Virus Research. In this episode, we speak with two outstanding researchers whose work is shaping the future of influenza and respiratory virus science. This conversation forms part of our three-part series on life as a scientist. Our guests are two recent ESWI Conference prize winners:
Dr Kevin Ciminski, recipient of the Claude Hannoun Prize for Best Body of Work. He leads an independent research group at the Institute of Virology, University Medical Center Freiburg in Germany, where he studies virus–host interactions of emerging zoonotic influenza viruses.
Dr. Kevin Ciminski is a junior research group leader at the Institute of Virology, University Medical Center Freiburg, Germany. His research focuses on virus-host interactions of emerging zoonotic viruses, including the elicited host immune response to viral infections, immunopathology, and transcriptional consequences. Kevin completed his PhD in 2020, studying the previously unknown bat-derived influenza A viruses H17N10 and H18N11 and assessing their zoonotic potential. In 2022, he received seed funding from the University Medical Center Freiburg through the Hans A. Krebs Medical Scientist Program to establish himself as an independent junior research group leader. Since 2023, Kevin is a visiting scientist at the Colorado State University in Fort Collins in the Department of Microbiology, Immunology and Pathology
Dr Marios Koutsakos, awarded the Young Scientist Vaccine Innovation Award. He is a Group Leader at the Doherty Institute in Melbourne, Australia, focusing on influenza B viruses, immune imprinting, and developing broader and more durable influenza vaccine strategies.
Dr Marios Koutsakos completed undergraduate and post-graduate studies at Imperial College in London. He subsequently undertook a PhD and post-doctoral training in the Department of Microbiology and Immunology, University of Melbourne, focusing on understanding protective immunity to influenza B viruses He is now a group leader at the Doherty Institute, working on dissecting the antigenic evolution of influenza viruses as well as the evolution of antibody-mediated immunity to influenza viruses in order to improve vaccine design.
Together, they explore what it means to build a scientific career, define a niche, establish a laboratory and contribute to an international research community. They reflect on the pivotal moments that drew them into virology, the balance between specialised research and big-picture questions, and the skills that have mattered most in their professional growth. They also share lessons learned from mentors and consider where early career scientists can make the greatest impact in the decade ahead.